Stocks In Focus

Chart Forecasts: NVD, CUR, MESA

Novadel Pharma, Mesa Air Group, and Neuralstem are reviewed from a technical viewpoint.

Published: Monday, November 2, 2009 @ 8:34 AM PST
Rating N/A
Stocks are fighting to recover from last week's selloff before further losses are taken, though we're still seeing more stocks that appear to be headed lower rather than higher. Among the most interesting today are Neuralstem, Inc. (AMEX:CUR), Novadel Pharma Inc. (AMEX:NVD), and Mesa Air Group, Inc. (NASDAQ:MESA). Here's a closer technical look at each one.

As of my last look at Mesa Air Group, Inc. (NASDAQ:MESA) on October 29th, I was right in my expectation that the stock would tumble a little further to a key support level; I was wrong about how little time it would take to get there.

On Friday, MESA gapped lower - and under a key support line - to hit a low of $0.15 before closing at $0.166. If you recall (and the chart shows this), that was where the last remaining support line for Mesa Air Group shares was at the time. 

So what? As of right now, I have serious doubts that the support line is intact. While MESA is only barely under it, there seems to be little effort to jump-start a rebound here. I've got a bad feeling Mesa Air Group has already broken the floor, and the meltdown is on a delayed reaction.

If and when (I'm still not fully convinced) the breakdown takes hold, the $0.11 area is the nearest likely support level for Mesa Air Group.



----------------------------------------------------------------------
Sign-up for Free to Receive Future Commentary
and Trading Alerts on CUR, MESA, and NVD.

----------------------------------------------------------------------

The bad news for current Neuralstem, Inc. (AMEX:CUR) owners is that the stock is trying hard to crack a major support level. The good news is here's another floor just under the first one. The other bad news is that "just under the first one" is a relative description - it's about 20% away.

Over the last week, CUR has been relying on support at $1.25. Shares can't rest there forever without some progress though... a fact that was accented today when Neuralstem quietly hit $1.24. 

If the support line as already broken as I believe it is, then Neuralstem is already headed back to $1.01. That's where we saw support (lots of it) between May and August. Based on that strong history though, I'd be very surprised if CUR falls under that line.



Before anybody jumps on board the apparent strength we're seeing from Novadel Pharma Inc. (AMEX:NVD) today, you should know it's nothing we haven't seen before. All the prior instances did nothing helpful for the stock either.

As you can see from the chart, Novadel Pharma shares are just dealing with a truckload of horizontal resistance. And yes, there is a layer of it around today's high of $0.32. Even if NVD does break through it once and for all though, there's still another ceiling around $0.41.

Bottom line? Novadel Pharma may be impressive today, but don't be fooled. We've seen the same setup go nowhere over the last several months. NVD only belongs on your watchlist, and will only be interesting above $0.41.



If you'd like to know of any changes in our opinion of NVD, CUR, and MESA (or if we officially recommend them as trades), be sure to sign up for our free newsletter today. It's delivered weekly.
Rate It : 1 2 3 4 5

 
Post A Comment
 
 
 
 
Search SCN
Bookmark and Share

Get the SCN
Newsletter Today!

Find out WHAT's Hot and What's Not from Top Traders and Investors.

Gain Insight into Which Small Cap Growth Stocks Have the Potential for Monster Returns.

Identify Market Trends and Changes Before the Rest of the Crowd.

Whitelist Us

Having Trouble Getting Our Email Newsletter?  Whitelist Us.

Click here for more info...

Fri, Mar 12, 2010 @ 10:53 AM PST
Considering about half of a stock's individual performance relies on sector and industry influence rather than the company's merits, it makes sense to stay abreast of industry trends. With that in mind...
Rating N/A
Fri, Mar 05, 2010 @ 10:25 AM PST
Are there any sectors or industries of any market cap that have simply been overlooked by the bulls and the media over the last twelve months? Sure, and they're very undervalued as a result. We'll take...
Rating 5
Fri, Feb 26, 2010 @ 12:29 PM PST
It was a busy week on the economic announcement front. Lots of housing and real estate data, in particular, was spewed forth from the media machine without putting it all in its proper perspective. I want...
Rating N/A
Fri, Feb 19, 2010 @ 11:30 AM PST
Before anyone gets hysterical about looming interest rate increases, take a breath, and keep reading. While the news writers made something more than it as (as usual) in the case of yesterday's increase...
Rating N/A
Fri, Feb 12, 2010 @ 12:12 PM PST
Another wild week didn't leave us short of some great comments and observations at the site. Among the most important include looks at Associated Banc-Corp (ASBC), Rexahn Pharmaceuticals (RNN), Washington...
Rating N/A
SmallCap Network Newsletters

This community is currently in beta and is constantly undergoing active development.  Please be patient as we strive to bring you a usable, full-featured community that you will enjoy.  If you should have any questions, problems, suggestions, feature requests, rants, and/or raves, please do not hesitate to let us know by writing us as : webmaster@smallcapnetwork.com.